However, the increase in circulating agonistic AT1 receptor autoantibodies may also play a major role in BBB disruption, as patients with MetS show significantly higher levels of AT1 receptor autoantibodies, which lead to dysregulation of the SN RAS as observed in the MetS rat model [81]. Here, AGTR1 is linked to metabolic syndrome.